Table 7. Univariate and Multivariate analysis for multifocal PSMs.
| Variables | Univariate analysis | Multivariate analysis | |||||
|---|---|---|---|---|---|---|---|
| OR | 95% CI | P value | OR | 95% CI | P value | ||
| Age | 0.99 | 0.962–1.029 | 0.772 | ||||
| BMI | 0.979 | 0.913–1.069 | 0.764 | ||||
| PSA | 1.651 | 2.947–7.856 | <0.001* | 3.5 | 1.993–6.147 | <0.001* | |
| NLR | 1.018 | 0.884–1.173 | 0.799 | ||||
| PLR | 0.999 | 0.991–1.000 | 0.06 | ||||
| LMR | 1.084 | 0.996–1.256 | 0.059 | 1.179 | 1.023–1.358 | 0.023* | |
| Prognostic nutritional index | 0.995 | 0.961–1.044 | 0.936 | ||||
| Biopsy Gleason sum (≥8 vs. <8) | 1.414 | 1.474–3.747 | <0.001* | 6.867 | 0.461–1.630 | 0.658 | |
| Perineural invasion | 4.04 | 2.375–6.875 | <0.001* | 3.446 | 1.863–6.372 | <0.001* | |
| SVI | 4.822 | 2.588–8.985 | <0.001* | 2.064 | 0.991–4.298 | 0.053 | |
| Pathologic Gleason sum (≥8 vs. <8) | 5.406 | 3.301–8.851 | <0.001* | 3.931 | 2.078–7.436 | <0.001* | |
*, statistically significant. BMI, body mass index; PSA, prostate specific antigen; NLR, neutrophil to lymphocyte ratio; PLR, platelets to lymphocyte ratio; LMR, lymphocyteto monocyte ratio; SVI, seminal vesicle invasion.